Chignolo d'Isola, Italy

Massimo Previtali


 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Chignolo d'Isola, IT (2014)
  • Castelleone, IT (2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Massimo Previtali: Innovator in Pharmaceutical Chemistry

Introduction

Massimo Previtali is a notable inventor based in Chignolo d'Isola, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of two patents to his name, Previtali's work focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Previtali's latest patents include a process for the preparation of triazolo[4,5-D] pyrimidine cyclopentane compounds. This invention relates to a method for synthesizing these compounds, which are useful in the preparation of ticagrelor and its pharmaceutically acceptable salts. Additionally, he has developed amino alcohol derivatives that exhibit therapeutic activities by blocking secondary products of lipid oxidative stress. These derivatives are suitable for treating disorders associated with reactive carbonyl compounds.

Career Highlights

Throughout his career, Massimo Previtali has worked with reputable organizations, including Flamma S.p.a. and Università degli Studi di Milano. His experience in these institutions has allowed him to advance his research and contribute to the field of pharmaceutical sciences.

Collaborations

Previtali has collaborated with esteemed colleagues such as Renato Canevotti and Gianpaolo Negrisoli. These partnerships have further enriched his research endeavors and have led to the development of impactful innovations.

Conclusion

Massimo Previtali's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…